Grape seed proanthocyanidins repress the hepatic lipid regulators miR-33 and miR-122 in rats

Molecular Nutrition and Food Research

Volumn 56, Issue 11, 2012, Pages 1636-1646

  Baselga Escudero, Laura ^a   Bladé, Cinta ^a   Ribas Latre, Aleix ^a   Casanova, Ester ^a   Salvadó, M Josepa ^a   Arola, Lluis ^a   Arola Arnal, Anna ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Abca1; Fas; Flavonoids; Hepatocytes; MicroRNAs

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; CHOLESTEROL; FAS ANTIGEN; FLAVONOL DERIVATIVE; GRAPE SEED EXTRACT; GRAPE SEED PROANTHOCYANIDINS; MICRORNA; MIRN122 MICRORNA, RAT; MIRN33 MICRORNA, RAT; PROANTHOCYANIDIN; TNFRSF6 PROTEIN, RAT; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIPID METABOLISM; LIVER; MALE; METABOLISM; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTIGENS, CD95; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CHOLESTEROL; FLAVONOLS; GENE EXPRESSION REGULATION; GRAPE SEED EXTRACT; LIPID METABOLISM; LIVER; MALE; MICRORNAS; PROANTHOCYANIDINS; RATS; RATS, WISTAR; TRIGLYCERIDES;

RATTUS; VITACEAE;

EID: 84867956754     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200237     Document Type: Article

References (47)

1. Zamora-Ros, R., Andres-Lacueva, C., Lamuela-Raventós, R. M., Berenguer, T. et al., Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J. Am. Diet. Assoc. 2010, 110, 390-398.
2. Chun, O. K., Chung, S. J., Song, W. O., Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007, 137, 1244-1252.
3. Wang, Y., Chung, S.-J., Song, W. O., Chun, O. K., Estimation of daily proanthocyanidin intake and major food sources in the U.S. diet. J. Nutr. 2011, 141, 447-452.
4. Bagchi, D., Sen, C. K., Ray, S. D., Das, D. K. et al., Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat. Res. 2003, 523-524, 87-97.
5. Llopiz, N., Puiggrós, F., Céspedes, E., Arola, L. et al., Antigenotoxic effect of grape seed procyanidin extract in FAO cells submitted to oxidative stress J. Agric. Food Chem. 2004, 52, 1083-1087.
6. Martinez-Micaelo, N., González-Abuín, N., Terra, X., Richart, C. et al., Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-kB activation through a p105/p50 regulatory mechanism in macrophage inflammation. Biochem. J. 2012, 441, 653-663.
7. Terra, X., Palozza, P., Fernandez-Larrea, J., Ardevol, A. et al., Procyanidin dimer B1 and trimer C1 impair inflammatory response signalling in human monocytes. Free Radical Res. 2011, 45, 611-619.
8. Lizarraga, D., Lozano, C., Briedé, J. J., van Delft, J. H. et al., The importance of polymerization and galloylation for the antiproliferative properties of procyanidin-rich natural extracts. FEBS J. 2007, 274, 4802-4811.
9. Bladé, C., Arola, L., Salvadó, M.-J., Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms. Mol. Nutr. Food Res. 2010, 54, 37-59.
10. Montagut, G., Bladé, C., Blay, M., Fernández-Larrea, J. et al., Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance. J. Nutr. Biochem. 2010, 21, 961-967.
11. Del Bas, J. M., Fernández-Larrea, J., Blay, M., Ardévol, A. et al., Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats FASEB J. 2005, 19, 479-481.
12. Quesada, H., Díaz, S., Pajuelo, D., Fernández-Iglesias, A. et al., The lipid-lowering effect of dietary proanthocyanidins in rats involves both chylomicron-rich and VLDL-rich fractions. Br. J. Nutr. 2012, 108, 208-217.
13. Quesada, H., del Bas, J., Pajuelo, D., Díaz, S. et al., Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int. J. Obes. (Lond) 2009, 33, 1007-1012.
14. Baiges, I., Palmfeldt, J., Bladé, C., Gregersen, N. et al., Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet. Mol. Cell. Proteomics 2010, 9, 1499-1513.
15. Moore, K. J., Rayner, K. J., Suárez, Y., Fernández-Hernando, C., The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu. Rev. Nutr. 2011, 31, 49-63.
16. Fernandez-Hernando, C., Suarez, Y., Rayner, K. J., Moore, K. J., MicroRNAs in lipid metabolism. Curr. Opin. Lipidol. 2011, 22, 86-92.
17. Goedeke, L., Fernández-Hernando, C., Regulation of cholesterol homeostasis. Cell. Mol. Life Sci., 2012, 69, 915-930.
18. Breving, K., Esquela-Kerscher, A., The complexities of microRNA regulation: mirandering around the rules. Int. J. Biochem. Cell Biol. 2010, 42, 1316-1329.
19. David, P., B. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136, 215-233.
20. Forman, J. J., The code within the code: microRNAs target coding regions. Cell Cycle 2010, 9, 1533-1541.
21. Heneghan, H. M., Miller, N., Kerin, M. J., Role of microRNAs in obesity and the metabolic syndrome. Obes. Rev. 2010, 11, 354-361.
22. Fernández-Valverde, S. L., Taft, R. J., Mattick, J. S., MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes 2011, 60, 1825-1831.
23. Ferland-McCollough, D., Ozanne, S., Siddle, K., Willis, A. et al., The involvement of microRNAs in type 2 diabetes. Biochem. Soc. Trans. 2010, 38, 1565-1570.
24. Alexander, R., Lodish, H., Sun, L., MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin. Ther. Tar. 2011, 15, 623-636.
25. Lewis, A., Jopling, C., Regulation and biological function of the liver-specific miR-122. Biochem. Soc. Trans. 2010, 38, 1553-1557.
26. Saini, S., Arora, S., Majid, S., Shahryari, V. et al., Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. 2011, 4, 1698-1709.
27. Tili, E., Michaille, J., Resveratrol, MicroRNAs, inflammation, and cancer. J. Nucleic Acids 2011, 2011, 102431.
28. Wang, H., Bian, S., Yang, C. S., Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1β ± 10.1093/carcin/bgr218. Carcinogenesis 2011, 32, 1881-1889.
29. Wen, X.-Y., Wu, S.-Y., Li, Z.-Q., Liu, Z.-q. et al., Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of MiRNAs in HepG2 cancer cells. Phytother. Res. 2009, 23, 778-784.
30. Chen, Y., Zaman, M. S., Deng, G., Majid, S. et al., MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res. 2011, 4, 76-86.
31. Arola-Arnal, A., Bladé, C., Proanthocyanidins modulate microRNA expression in human HepG2 cells. PLoS One 2011, 6, e25982.
32. Serra, A., Maciá, A., Romero, M.-P., Valls, J. et al., Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models. Br. J. Nutr. 2010, 103, 944-952.
33. Martí, M. P., Pantaleón, A., Rozek, A., Soler, A., et al., Rapid analysis of procyanidins and anthocyanins in plasma by microelution SPE and ultra-HPLC. J. Sep. Sci. 2010, 33, 2841-2853.
34. Folch, J., Lees, M., Stanley, G., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
35. McCullough, M. L., Peterson, J. J., Patel, R., Jacques, P. F. et al., Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am. J. Clin. Nutr. 2012, 95, 454-464.
36. Del Bas, J. M., Ricketts, M. L., Baiges, I., Quesada, H. et al., Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner. Mol. Nutr. Food Res. 2008, 52, 1172-1181.
37. Del Bas, J. M., Ricketts, M.-L., Vaqué, M., Sala, E. et al., Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. Mol. Nutr. Food Res. 2009, 53, 805-814.
38. Esau, C., Davis, S., Murray, S. F., Yu, X. X. et al., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3, 87-98.
39. Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L. et al., Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478, 404-407.
40. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661.
41. Fernandez-Hernando, C., Moore, K. J., MicroRNA modulation of cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2378-2382.
42. Cavelier, C., Lorenzi, I., Rohrer, L., von Eckardstein, A., Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim. Biophys. Acta 2006, 1761, 655-666.
43. Sahoo, D., Trischuk, T. C., Chan, T., Drover, V. A. B. et al., ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes. J. Lipid Res. 2004, 45, 1122-1131.
44. Iliopoulos, D., Drosatos, K., Hiyama, Y., Goldberg, I. J. et al., MicroRNA-370 controls the expression of microRNA-122 and Cpt1β ± and affects lipid metabolism. J. Lipid Res. 2010, 51, 1513-1523.
45. Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T. et al., MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328, 1566-1569.
46. Kuzuhara, T., Sei, Y., Yamaguchi, K., Suganuma, M. et al., DNA and RNA as new binding targets of green tea catechins. J. Biol. Chem. 2006, 281, 17446-17456.
47. Xiao, J., Kai, G., A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship. Crit. Rev. Food Sci. Nutr. 2011, 52, 85-101.